Clarithromycin Versus Metronidazole in First-Line <i>Helicobacter Pylori</i> Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis

Clarithromycin Versus Metronidazole in First-Line <i>Helicobacter Pylori</i> Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis

Background: International treatment guidelines for <i>Helicobacter pylori</i> infection recommend a proton pump inhibitor (PPI)/amoxicillin/clarithromycin (CAM) regimen (PAC) or PPI/amoxicillin/metronidazole (MNZ) regimen (PAM) as first-line therapy based on culture and sensitivity testi...

Full description

Bibliographic Details
Main Authors: Masaki Murata, Mitsushige Sugimoto, Hitomi Mizuno, Takeshi Kanno, Kiichi Satoh
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Journal of Clinical Medicine
Subjects:
<i>helicobacter pylori</i>
eradication therapy
clarithromycin
metronidazole
triple therapy
resistant
Online Access:https://www.mdpi.com/2077-0383/9/2/543

Internet

https://www.mdpi.com/2077-0383/9/2/543

Similar Items